Targeting Leukemia Cells with Gemtuzumab Ozogamicin

Saved in:
Bibliographic Details
Published inCancer practice Vol. 8; no. 5; pp. 254 - 256
Main Author Treish, Imad M.
Format Journal Article
LanguageEnglish
Published Boston, MA, USA Blackwell Science Inc 01.09.2000
Subjects
Abdominal Pain - chemically induced
Aminoglycosides
Anti-Bacterial Agents - economics
Anti-Bacterial Agents - immunology
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibodies, Monoclonal - economics
Antibodies, Monoclonal - immunology
Antibodies, Monoclonal - pharmacology
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Asthenia - chemically induced
Drug Costs
Fever - chemically induced
Forecasting
Headache - chemically induced
Humans
Immunotoxins - economics
Immunotoxins - immunology
Immunotoxins - pharmacology
Immunotoxins - therapeutic use
Leukemia, Myeloid, Acute - drug therapy
Nausea - chemically induced
Treatment Outcome
Vomiting - chemically induced
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:CPRA85010
ark:/67375/WNG-TL9VM9NZ-M
istex:5FBB31B4067C5BA6A152C4F2E636E403A0299627
American Cancer Society, 1180 Avenue of the Americas, New York, NY 10036.
Queries and contributions for Drug Update may be sent to the Department Editors at
Cancer Practice
Department Editors: Robert J. Ignoffo, PharmD; and Reginald S. King, PharmD.
ISSN:1065-4704
1523-5394
DOI:10.1046/j.1523-5394.2000.85010.x